Global Biologic-Device Combination Products Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07242207

Publication Date:

July 2, 2024

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Biologic-Device Combination Products market size was valued at US$ 6573.8 million in 2023. With growing demand in downstream market, the Biologic-Device Combination Products is forecast to a readjusted size of US$ 12270 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Biologic-Device Combination Products market. Biologic-Device Combination Products are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biologic-Device Combination Products. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biologic-Device Combination Products market.
A biologic-device combination product is a marriage between two partners with "cultural differences". There are clear differences in the development, review, and commercialization processes of the biologic and the device. Some biological products are associated with a device or drug to form a therapeutic product.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Biologic-Device Combination Products market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biologic-Device Combination Products market. It may include historical data, market segmentation by Type (e.g., Prefilled Syringes, Autoinjectors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biologic-Device Combination Products market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biologic-Device Combination Products market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biologic-Device Combination Products industry. This include advancements in Biologic-Device Combination Products technology, Biologic-Device Combination Products new entrants, Biologic-Device Combination Products new investment, and other innovations that are shaping the future of Biologic-Device Combination Products.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biologic-Device Combination Products market. It includes factors influencing customer ' purchasing decisions, preferences for Biologic-Device Combination Products product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biologic-Device Combination Products market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biologic-Device Combination Products market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biologic-Device Combination Products market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biologic-Device Combination Products industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biologic-Device Combination Products market.
Market Segmentation:
Biologic-Device Combination Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Prefilled Syringes
Autoinjectors
Others
Segmentation by application
Vaccines
Antithrombotic Drugs
Bioengineering Drugs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Baxter BioPharma Solution
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
Roselabs Group
West Pharma

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologic-Device Combination Products Market Size 2019-2030
2.1.2 Biologic-Device Combination Products Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologic-Device Combination Products Segment by Type
2.2.1 Prefilled Syringes
2.2.2 Autoinjectors
2.2.3 Others
2.3 Biologic-Device Combination Products Market Size by Type
2.3.1 Biologic-Device Combination Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologic-Device Combination Products Market Size Market Share by Type (2019-2024)
2.4 Biologic-Device Combination Products Segment by Application
2.4.1 Vaccines
2.4.2 Antithrombotic Drugs
2.4.3 Bioengineering Drugs
2.4.4 Others
2.5 Biologic-Device Combination Products Market Size by Application
2.5.1 Biologic-Device Combination Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologic-Device Combination Products Market Size Market Share by Application (2019-2024)
3 Biologic-Device Combination Products Market Size by Player
3.1 Biologic-Device Combination Products Market Size Market Share by Players
3.1.1 Global Biologic-Device Combination Products Revenue by Players (2019-2024)
3.1.2 Global Biologic-Device Combination Products Revenue Market Share by Players (2019-2024)
3.2 Global Biologic-Device Combination Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biologic-Device Combination Products by Regions
4.1 Biologic-Device Combination Products Market Size by Regions (2019-2024)
4.2 Americas Biologic-Device Combination Products Market Size Growth (2019-2024)
4.3 APAC Biologic-Device Combination Products Market Size Growth (2019-2024)
4.4 Europe Biologic-Device Combination Products Market Size Growth (2019-2024)
4.5 Middle East & Africa Biologic-Device Combination Products Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biologic-Device Combination Products Market Size by Country (2019-2024)
5.2 Americas Biologic-Device Combination Products Market Size by Type (2019-2024)
5.3 Americas Biologic-Device Combination Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic-Device Combination Products Market Size by Region (2019-2024)
6.2 APAC Biologic-Device Combination Products Market Size by Type (2019-2024)
6.3 APAC Biologic-Device Combination Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologic-Device Combination Products by Country (2019-2024)
7.2 Europe Biologic-Device Combination Products Market Size by Type (2019-2024)
7.3 Europe Biologic-Device Combination Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologic-Device Combination Products by Region (2019-2024)
8.2 Middle East & Africa Biologic-Device Combination Products Market Size by Type (2019-2024)
8.3 Middle East & Africa Biologic-Device Combination Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biologic-Device Combination Products Market Forecast
10.1 Global Biologic-Device Combination Products Forecast by Regions (2025-2030)
10.1.1 Global Biologic-Device Combination Products Forecast by Regions (2025-2030)
10.1.2 Americas Biologic-Device Combination Products Forecast
10.1.3 APAC Biologic-Device Combination Products Forecast
10.1.4 Europe Biologic-Device Combination Products Forecast
10.1.5 Middle East & Africa Biologic-Device Combination Products Forecast
10.2 Americas Biologic-Device Combination Products Forecast by Country (2025-2030)
10.2.1 United States Biologic-Device Combination Products Market Forecast
10.2.2 Canada Biologic-Device Combination Products Market Forecast
10.2.3 Mexico Biologic-Device Combination Products Market Forecast
10.2.4 Brazil Biologic-Device Combination Products Market Forecast
10.3 APAC Biologic-Device Combination Products Forecast by Region (2025-2030)
10.3.1 China Biologic-Device Combination Products Market Forecast
10.3.2 Japan Biologic-Device Combination Products Market Forecast
10.3.3 Korea Biologic-Device Combination Products Market Forecast
10.3.4 Southeast Asia Biologic-Device Combination Products Market Forecast
10.3.5 India Biologic-Device Combination Products Market Forecast
10.3.6 Australia Biologic-Device Combination Products Market Forecast
10.4 Europe Biologic-Device Combination Products Forecast by Country (2025-2030)
10.4.1 Germany Biologic-Device Combination Products Market Forecast
10.4.2 France Biologic-Device Combination Products Market Forecast
10.4.3 UK Biologic-Device Combination Products Market Forecast
10.4.4 Italy Biologic-Device Combination Products Market Forecast
10.4.5 Russia Biologic-Device Combination Products Market Forecast
10.5 Middle East & Africa Biologic-Device Combination Products Forecast by Region (2025-2030)
10.5.1 Egypt Biologic-Device Combination Products Market Forecast
10.5.2 South Africa Biologic-Device Combination Products Market Forecast
10.5.3 Israel Biologic-Device Combination Products Market Forecast
10.5.4 Turkey Biologic-Device Combination Products Market Forecast
10.5.5 GCC Countries Biologic-Device Combination Products Market Forecast
10.6 Global Biologic-Device Combination Products Forecast by Type (2025-2030)
10.7 Global Biologic-Device Combination Products Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Biologic-Device Combination Products Product Offered
11.1.3 BD Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Gerresheimer
11.2.1 Gerresheimer Company Information
11.2.2 Gerresheimer Biologic-Device Combination Products Product Offered
11.2.3 Gerresheimer Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gerresheimer Main Business Overview
11.2.5 Gerresheimer Latest Developments
11.3 Nipro Corporation
11.3.1 Nipro Corporation Company Information
11.3.2 Nipro Corporation Biologic-Device Combination Products Product Offered
11.3.3 Nipro Corporation Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Nipro Corporation Main Business Overview
11.3.5 Nipro Corporation Latest Developments
11.4 Schott
11.4.1 Schott Company Information
11.4.2 Schott Biologic-Device Combination Products Product Offered
11.4.3 Schott Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Schott Main Business Overview
11.4.5 Schott Latest Developments
11.5 Stevanato
11.5.1 Stevanato Company Information
11.5.2 Stevanato Biologic-Device Combination Products Product Offered
11.5.3 Stevanato Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Stevanato Main Business Overview
11.5.5 Stevanato Latest Developments
11.6 Baxter BioPharma Solution
11.6.1 Baxter BioPharma Solution Company Information
11.6.2 Baxter BioPharma Solution Biologic-Device Combination Products Product Offered
11.6.3 Baxter BioPharma Solution Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Baxter BioPharma Solution Main Business Overview
11.6.5 Baxter BioPharma Solution Latest Developments
11.7 Rovi CM
11.7.1 Rovi CM Company Information
11.7.2 Rovi CM Biologic-Device Combination Products Product Offered
11.7.3 Rovi CM Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Rovi CM Main Business Overview
11.7.5 Rovi CM Latest Developments
11.8 Terumo
11.8.1 Terumo Company Information
11.8.2 Terumo Biologic-Device Combination Products Product Offered
11.8.3 Terumo Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Terumo Main Business Overview
11.8.5 Terumo Latest Developments
11.9 Vetter
11.9.1 Vetter Company Information
11.9.2 Vetter Biologic-Device Combination Products Product Offered
11.9.3 Vetter Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Vetter Main Business Overview
11.9.5 Vetter Latest Developments
11.10 Catalent
11.10.1 Catalent Company Information
11.10.2 Catalent Biologic-Device Combination Products Product Offered
11.10.3 Catalent Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Catalent Main Business Overview
11.10.5 Catalent Latest Developments
11.11 Taisei Kako
11.11.1 Taisei Kako Company Information
11.11.2 Taisei Kako Biologic-Device Combination Products Product Offered
11.11.3 Taisei Kako Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Taisei Kako Main Business Overview
11.11.5 Taisei Kako Latest Developments
11.12 Roselabs Group
11.12.1 Roselabs Group Company Information
11.12.2 Roselabs Group Biologic-Device Combination Products Product Offered
11.12.3 Roselabs Group Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Roselabs Group Main Business Overview
11.12.5 Roselabs Group Latest Developments
11.13 West Pharma
11.13.1 West Pharma Company Information
11.13.2 West Pharma Biologic-Device Combination Products Product Offered
11.13.3 West Pharma Biologic-Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 West Pharma Main Business Overview
11.13.5 West Pharma Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂